Independent report

The Biomedical Catalyst: an evaluation report

This report contains the findings of an independent review and impact assessment of the Biomedical Catalyst programme.

Documents

Biomedical Catalyst Evaluation

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@innovateuk.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Biomedical Catalyst Evaluation - Annexes

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email web@innovateuk.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Innovate UK and the Medical Research Council (MRC) commissioned Ipsos Mori to carry out a 2-stage review of the Biomedical Catalyst. This report provides the results of the first stage of the evaluation process.

Some of the report’s main findings include:

  • projects receiving Biomedical Catalyst funding progress faster than they would otherwise have done
  • Biomedical Catalyst funding encourages companies to switch from low risk / low return projects to those with high risk / higher return
  • stakeholders agreed that the Biomedical Catalyst aligns with Innovate UK and MRC strategies
  • applicants thought the application process was straightforward and encouraged high-quality submissions
  • marketing to the biopharma and academic communities was successful
  • the Biomedical Catalyst should seek to increase outreach to the medtech community and emerging sectors such as digital health

Future evaluation of the Biomedical Catalyst

The second phase of the evaluation will begin in 2017 and will build upon this baseline study. It will report on the outcomes and impacts since the launch of the Biomedical Catalyst.

About the Biomedical Catalyst

The Biomedical Catalyst is a partnership between Innovate UK and the MRC. It supports the most innovative life sciences opportunities. Its aims are to de-risk innovative science and commercialise the ideas that come from academia and industry. It helps UK SMEs develop into competitive and sustainable businesses.

Published 21 March 2017